.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Medtronic
QuintilesIMS
Citi
McKinsey
Farmers Insurance
Queensland Health
Teva
Argus Health
Moodys

Generated: November 21, 2017

DrugPatentWatch Database Preview

Amlodipine besylate; benazepril hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for amlodipine besylate; benazepril hydrochloride and what is the scope of amlodipine besylate; benazepril hydrochloride freedom to operate?

Amlodipine besylate; benazepril hydrochloride
is the generic ingredient in two branded drugs marketed by Apotex Inc, Aurobindo Pharma Ltd, Mylan, Dr Reddys Labs Inc, Watson Labs Inc, Novartis, Lupin Pharms, Teva Pharms, Par Pharm, and Watson Labs, and is included in twelve NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are fifty drug master file entries for amlodipine besylate; benazepril hydrochloride. Twenty-three suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for amlodipine besylate; benazepril hydrochloride

Pharmacology for amlodipine besylate; benazepril hydrochloride

Tentative approvals for AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
u► Subscribe2.5MG; 10MGCAPSULE; ORAL
u► Subscribe10MG; 20MGCAPSULE; ORAL
u► Subscribe5MG; 20MGCAPSULE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
LOTREL
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL020364-003Mar 3, 1995ABRXYesNo► Subscribe► Subscribe ► Subscribe
Par Pharm
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL078381-004Jul 29, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL078466-006Jul 5, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL077375-003May 21, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL077179-006Jul 5, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL077890-004Oct 14, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL202239-001Sep 5, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL077890-003Oct 14, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL091431-001Dec 30, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL077375-001May 21, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: amlodipine besylate; benazepril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
LOTREL
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL020364-005Jun 20, 2002► Subscribe► Subscribe
Novartis
LOTREL
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL020364-005Jun 20, 2002► Subscribe► Subscribe
Novartis
LOTREL
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL020364-002Mar 3, 1995► Subscribe► Subscribe
Novartis
LOTREL
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL020364-003Mar 3, 1995► Subscribe► Subscribe
Novartis
LOTREL
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL020364-003Mar 3, 1995► Subscribe► Subscribe
Novartis
LOTREL
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL020364-004Mar 3, 1995► Subscribe► Subscribe
Novartis
LOTREL
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL020364-004Mar 3, 1995► Subscribe► Subscribe
Novartis
LOTREL
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL020364-004Mar 3, 1995► Subscribe► Subscribe
Novartis
LOTREL
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL020364-005Jun 20, 2002► Subscribe► Subscribe
Novartis
LOTREL
amlodipine besylate; benazepril hydrochloride
CAPSULE;ORAL020364-007Apr 11, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Harvard Business School
Accenture
US Army
Federal Trade Commission
US Department of Justice
McKinsey
Express Scripts
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot